Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for postoperative stress hyperglycemia after acute abdominal surgery
2020-004614-35Phase 2Terminated
- Sponsor
- Ismail Gögenur
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dapagliflozin in hyperglycemia (2 arms), sponsored by Ismail Gögenur. Primary endpoint: Percentage of time in target blood glucose range. Started Mar 2021; status: terminated.
02
Drugs
dapagliflozin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on 2020-004614-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004614-35.